Genetic Risk Factors for Adverse Drug Reactions
The use of medicines may in some cases be associated with the development of drug-induced diseases (DIDs) аnd other adverse drug reactions (ADRs), which leads to an increase in morbidity/mortality rates, and/or symptoms forcing a patient to seek medical attention or resulting in hospitalisation. ADR...
Main Authors: | D. A. Sychev, M. S. Chernyaeva, O. D. Ostroumova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2022-04-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/245 |
Similar Items
-
Pharmacogenetics of carbamazepine
by: N. A. Shnayder, et al.
Published: (2020-01-01) -
Risk factors for adverse drug reactions associated with clopidogrel therapy
by: Mugosa Snezana, et al.
Published: (2022-04-01) -
Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk
by: Alfredo Mauriello, et al.
Published: (2023-11-01) -
Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia
by: Angela Wu, et al.
Published: (2023-09-01) -
Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review
by: Johanna Raymond, et al.
Published: (2021-01-01)